Cargando…
Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
Intracerebral (i.c.) and subcutaneous (s.c.) 9L tumours were treated simultaneously with various doses of the nitrosoureas, BCNU or CCNU, and 2.5 mmol kg-1 of misonidazole (MISO). After 24 h, tumours were removed, dissociated into single cell suspensions and the cells plated for colony formation. In...
Autores principales: | Wheeler, K. T., Wallen, C. A., Wolf, K. L., Siemann, D. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976835/ https://www.ncbi.nlm.nih.gov/pubmed/6733024 |
Ejemplares similares
-
Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985) -
Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
por: Mulcahy, R. T., et al.
Publicado: (1982) -
Chemopotentiation in vivo: no loss of sensitization with fractionation.
por: Hill, S. A., et al.
Publicado: (1984) -
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
por: Adams, G. E., et al.
Publicado: (1984) -
In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
por: Siemann, D. W., et al.
Publicado: (1984)